Global Batten Disease Treatment Market Set for Rapid Growth to Reach Around USD 41.39 by 2023

27-Mar-2018 | Zion Market Research

Zion Market Research has published a new report titled “Batten Disease Treatment Market by Disease Type (Infantile, Late Infantile, Juvenile, and Adult) and by Therapy Type includes Occupational Therapy and Physical Therapy: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2023”. According to the report, global batten disease treatment market was valued at approximately USD 35.09 million in 2017, and it is expected to generate revenue of around USD 41.39 million by the end of 2023, growing at the CAGR of around 2.79% between 2018 and 2023.

Batten disease is a genetically inherited, life-limiting neurodegenerative disorder it is also considered as lysosome shortage disease. Lysosome contains enzymes which breakdowns the protein and shortage of lysosome led to the huge buildup of proteins in the body. It is caused by the mutation in genes results in their inability to synthesize required protein. Due to this malfunctioning of the body can be observed in the children from 2 years of age to 10 years. Symptoms of this disease include the change in behavior, mental impairment, dementia, loss of vision and speech, motor reaction and others ultimately leads to death. This disease can be diagnosed by MRI or CT scan and few laboratory tests which include urine test, blood test, skin, and tissue sampling.

Request Sample Request Customization Buy Now

Browse the full "Batten Disease Treatment Market by Disease Type (Infantile, Late Infantile, Juvenile, and Adult) and by Therapy Type includes Occupational Therapy and Physical Therapy: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2023" report at https://www.zionmarketresearch.com/report/batten-disease-treatment-market

Global Batten disease treatment market

Global Batten disease treatment market is primarily driven by the increased prevalence of disease, increase in R&D and clinical trial are expected to fuel the market.There is no specific treatment and prevention of this disease are available in the market. In 2017, Brineuradrug developed by BioMarin got FDA approval for the treatment of Batten disease; vitamins are also used in the treatment which slows down the process of various symptoms. Various companies are conducting R&D for the development of new and effective drugs for the treatment of Batten disease are expected to support the growth of batten disease treatment market. However, lack of awareness among people and manufacturer are expected to hamper the growth of the market. The above-mentioned factors affect the growth of batten disease treatment market over the forecast period.

The Batten disease treatment market is segmented on the basis of Disease types such as Infantile NCL, Late Infantile NCL, Juvenile NCL, and Adult NCL. On the basis of therapy available for the treatment includes occupational and physical therapies for the treatment of Batten disease.

North America, Europe, Asia Pacific, Latin America and Middle East & Africa are the key regional Segments of global batten disease treatment market. North America is expected to dominate the market which is closely followed by Europe over the forecast period. Due to the increased prevalence of disease in these regions, ongoing clinical trials and R&D are expected to support the growth of batten disease treatment market. The Asia Pacific is expected to grow moderately over the forecast period due to lack of awareness in this region among people and manufacturer. Latin America, Middle East & Africa are expected to show considerable growth for this market in near future.

Some of the key players in batten disease treatment market includeReGenX Biosciences LLC, BioMarin Pharmaceuticals, and SenebBioSciences Inc. 

This report segments the global batten disease treatment market as follows:  

Global Batten Disease Treatment Market: Disease Type Segment Analysis

  • Infantile NCL
  • Late Infantile NCL
  • Juvenile NCL
  • Adult NCL

Global Batten Disease Treatment Market: Therapy type Segment Analysis

  • Occupational Therapy 
  • Physical Therapy

Global Batten Disease Treatment Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Download Brochure
Latest Published Reports

View All Published Reports